New drug LY3985863 put to the test in healthy volunteers
NCT ID NCT07030127
First seen Nov 01, 2025 · Last updated Apr 25, 2026 · Updated 23 times
Summary
This early-stage study tested a new drug called LY3985863 in 24 healthy Chinese adults to see if it is safe and what side effects it might cause. Participants received multiple doses under the skin or a placebo, and blood tests measured how the drug moves through the body. Since this is a Phase 1 trial in healthy people, there is no direct treatment benefit—the goal is to gather safety and drug-processing information for future research.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking University Third Hospital
Beijing, 100191, China
Conditions
Explore the condition pages connected to this study.